Response assessment in oncology trials: a radiographer RECIST service
The assessment of change in tumour burden is a crucial step for the evaluation of the activity and efficacy of novel cancer therapies in solid tumours. Clinical trials require imaging to be evaluated according to specific evaluation criteria to determine disease status. The most employed is Response Evaluation Criteria in Solid Tumours (RECIST v1.1). However, […]
Georgina Hopkinson, Dr Jonathan Taylor, Dr Peter Metherall, Dr Edward Johnston, Judith Sugden, Dr Christina Messiou
The Royal Marsden Hospital NHS Foundation Trust, Sheffield Teaching Hospitals NHS Foundation Trust